Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-Term Debt issuances (2016 - 2025)

Historic Short-Term Debt issuances for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 12 years, with Q1 2025 value amounting to -$6.0 million.

  • Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances fell 29769.36% to -$6.0 million in Q1 2025 from the same period last year, while for Feb 2025 it was $129.3 million, marking a year-over-year increase of 12080.64%. This contributed to the annual value of $149.6 million for FY2024, which is 37563.12% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Short-Term Debt issuances of -$6.0 million as of Q1 2025, which was down 29769.36% from -$13.1 million recorded in Q4 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances registered a high of $146.5 million during Q2 2024, and its lowest value of -$32.0 million during Q1 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Short-Term Debt issuances value was $4.0 million (recorded in 2022), while the average stood at $17.4 million.
  • Its Short-Term Debt issuances has fluctuated over the past 5 years, first soared by 44900.99% in 2023, then plummeted by 49245.03% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances (Quarter) stood at $18.0 million in 2021, then tumbled by 77.78% to $4.0 million in 2022, then plummeted by 155.3% to -$2.2 million in 2023, then tumbled by 492.45% to -$13.1 million in 2024, then skyrocketed by 54.22% to -$6.0 million in 2025.
  • Its Short-Term Debt issuances stands at -$6.0 million for Q1 2025, versus -$13.1 million for Q4 2024 and $1.9 million for Q3 2024.